Ignite Creation Date:
2024-05-06 @ 5:29 PM
Last Modification Date:
2024-10-26 @ 2:30 PM
Study NCT ID:
NCT05329649
Status:
RECRUITING
Last Update Posted:
2024-06-13
First Post:
2022-04-07
Brief Title:
Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Severe Sickle Cell Disease SCD
Sponsor:
Organization:
Vertex Pharmaceuticals Incorporated